(19)
(11)
EP 0 914 128 A1
(12)
(43)
Date of publication:
12.05.1999
Bulletin 1999/19
(21)
Application number:
97928011.0
(22)
Date of filing:
05.06.1997
(51)
International Patent Classification (IPC):
C07D
403/
12
( . )
A61K
9/
22
( . )
A61K
31/
505
( . )
A61P
9/
00
( . )
A61K
9/
00
( . )
A61K
31/
00
( . )
A61K
31/
506
( . )
A61P
9/
04
( . )
(86)
International application number:
PCT/US1997/009914
(87)
International publication number:
WO 1997/046241
(
11.12.1997
Gazette 1998/01)
(84)
Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
Designated Extension States:
AL LT LV RO
(30)
Priority:
06.06.1996
US 19960659463
(71)
Applicant:
ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)
(72)
Inventor:
MCNAY, John, L.
Fishers, IN 46038 (US)
(74)
Representative:
Hudson, Christopher Mark
Eli Lilly and Company Limited, Lilly Research Centre, Erl Wood Manor
Windlesham Surrey GU20 6PH
Windlesham Surrey GU20 6PH (GB)
(54)
FORMULATION AND METHOD FOR TREATING CONGESTIVE HEART FAILURE